Lista de obras - Jesper B. Andersen - Dominio Público Uruguay

A Gene Expression Signature Associated with Overall Survival in Patients with Hepatocellular Carcinoma Suggests a New Treatment Strategy.

artículo científico publicado en 2015

A Pan-Cancer Analysis Reveals High-Frequency Genetic Alterations in Mediators of Signaling by the TGF-β Superfamily

artículo científico publicado en 2018

A morphogenetic EphB/EphrinB code controls hepatopancreatic duct formation

scientific article published on 19 November 2019

A perspective on molecular therapy in cholangiocarcinoma: present status and future directions.

artículo científico publicado en 2014

Advances in cholangiocarcinoma research: report from the third Cholangiocarcinoma Foundation Annual Conference

artículo científico publicado en 2016

Adverse genomic alterations and stemness features are induced by field cancerization in the microenvironment of hepatocellular carcinomas

artículo científico publicado en 2017

An integrated genomic and epigenomic approach predicts therapeutic response to zebularine in human liver cancer

artículo científico publicado en 2010

An integrative approach unveils FOSL1 as an oncogene vulnerability in KRAS-driven lung and pancreatic cancer.

artículo científico publicado en 2017

Antitumor effects in hepatocarcinoma of isoform-selective inhibition of HDAC2.

artículo científico publicado en 2014

Application of patient-derived liver cancer cells for phenotypic characterization and therapeutic target identification

scientific article published on 14 December 2018

Causes of hOCT1-Dependent Cholangiocarcinoma Resistance to Sorafenib and Sensitization by Tumor-Selective Gene Therapy

article

Cholangiocarcinoma 2020: the next horizon in mechanisms and management

artículo científico publicado en 2020

Cholangiocarcinoma stem-like subset shapes tumor-initiating niche by educating associated macrophages

artículo científico publicado en 2016

Cholangiocarcinoma: State-of-the-art knowledge and challenges

scientific article published on 01 May 2019

Coactivation of AKT and β-Catenin in Mice Rapidly Induces Formation of Lipogenic Liver Tumors ⬇️

artículo científico publicado el 15 de febrero de 2011

Common Molecular Subtypes Among Asian Hepatocellular Carcinoma and Cholangiocarcinoma.

artículo científico publicado en 2017

Curcumin effectively inhibits oncogenic NF-κB signaling and restrains stemness features in liver cancer

artículo científico publicado en 2015

DNMT1 is a required genomic regulator for murine liver histogenesis and regeneration.

artículo científico publicado en 2016

Desmoplastic Tumor Microenvironment and Immunotherapy in Cholangiocarcinoma.

artículo científico publicado en 2018

Differential effects of FXR or TGR5 activation in cholangiocarcinoma progression

artículo científico publicado en 2017

Dual-initiation promoters with intertwined canonical and TCT/TOP transcription start sites diversify transcript processing

artículo científico publicado en 2020

Dysregulation of Iron Metabolism in Cholangiocarcinoma Stem-like Cells

artículo científico publicado en 2017

Epigenetic events involved in organic cation transporter 1-dependent impaired response of hepatocellular carcinoma to sorafenib

scientific article published on 11 February 2019

Epigenetic reprogramming modulates malignant properties of human liver cancer.

artículo científico publicado en 2014

Epigenome dysregulation in cholangiocarcinoma.

artículo científico publicado en 2017

Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA).

artículo científico publicado en 2016

Fibrolamellar hepatocellular carcinoma: a rare but distinct type of liver cancer

artículo científico publicado en 2015

Functional and genetic deconstruction of the cellular origin in liver cancer.

artículo científico publicado en 2015

Genetic Optimization of Liver Cancer Therapy: A Patient-Derived Primary Cancer Cell-Based Model

artículo científico publicado en 2016

Genomic Perturbations Reveal Distinct Regulatory Networks in Intrahepatic Cholangiocarcinoma

artículo científico publicado en 2017

Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors

artículo científico publicado en 2011

Genomic decoding of intrahepatic cholangiocarcinoma reveals therapeutic opportunities.

artículo científico publicado en 2013

Heterogeneity Among Liver Cancer—A Hurdle to Optimizing Therapy

artículo científico publicado en 2016

High mobility group A1 enhances tumorigenicity of human cholangiocarcinoma and confers resistance to therapy.

artículo científico publicado en 2017

Human hepatic cancer stem cells are characterized by common stemness traits and diverse oncogenic pathways.

artículo científico publicado en 2011

Identification of a Pan-Gamma-Secretase Inhibitor Response Signature for Notch-Driven Cholangiocarcinoma

scientific article published on 19 August 2019

Impact of microenvironment and stem-like plasticity in cholangiocarcinoma: molecular networks and biological concepts.

artículo científico

Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles

artículo científico publicado en 2017

Interaction between the 2'-5' oligoadenylate synthetase-like protein p59 OASL and the transcriptional repressor methyl CpG-binding protein 1

artículo científico publicado en 2004

Liver cancer oncogenomics: opportunities and dilemmas for clinical applications

artículo científico publicado en 2015

Long noncoding RNA HOTTIP/HOXA13 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients

artículo científico publicado en 2014

Loss of c-Met disrupts gene expression program required for G2/M progression during liver regeneration in mice

artículo científico publicado en 2010

Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties

artículo científico publicado en 2009

MIR21 drives resistance to Heat Shock Protein 90 inhibition in cholangiocarcinoma

artículo científico publicado en 2017

MYC activates stem-like cell potential in hepatocarcinoma by a p53-dependent mechanism.

artículo científico publicado en 2014

Metabolic rearrangements in primary liver cancers: cause and consequences

scientific article published on 30 October 2019

MicroRNA-27a-3p targets FoxO signalling to induce tumour-like phenotypes in bile duct cells

artículo científico publicado en 2022

Modeling pathogenesis of primary liver cancer in lineage-specific mouse cell types.

artículo científico publicado en 2013

Molecular Pathogenesis and Current Therapy in Intrahepatic Cholangiocarcinoma

artículo científico publicado en 2016

Molecular constituents of the extracellular matrix in rat liver mounting a hepatic progenitor cell response for tissue repair.

artículo científico publicado en 2013

Molecular pathogenesis of intrahepatic cholangiocarcinoma

artículo científico publicado en 2014

Molecular perturbations in cholangiocarcinoma: Is it time for precision medicine?

artículo científico publicado en 2019

Molecular profiling of intrahepatic cholangiocarcinoma: the search for new therapeutic targets

artículo científico publicado en 2017

Next-generation sequencing: application in liver cancer-past, present and future?

artículo científico

Notch signaling inhibits hepatocellular carcinoma following inactivation of the RB pathway.

artículo científico publicado en 2011

Oncogenic driver genes and the inflammatory microenvironment dictate liver tumor phenotype

artículo científico publicado en 2016

Phosphoprotein enriched in diabetes (PED/PEA15) promotes migration in hepatocellular carcinoma and confers resistance to sorafenib.

artículo científico publicado en 2017

Post-transcriptional regulation of RNase-L expression is mediated by the 3'-untranslated region of its mRNA

scientific article published on 19 January 2007

Progenitor-derived hepatocellular carcinoma model in the rat.

artículo científico publicado en 2010

RNAi screening of subtracted transcriptomes reveals tumor suppression by taurine-activated GABAA receptors involved in volume regulation.

artículo científico publicado en 2018

Reply

artículo científico publicado en 2017

Role of 2-5A-dependent RNase-L in senescence and longevity.

artículo científico publicado en 2006

SOX17 regulates cholangiocyte differentiation and acts as a tumor suppressor in cholangiocarcinoma.

artículo científico publicado en 2017

Sequential transcriptome analysis of human liver cancer indicates late stage acquisition of malignant traits.

artículo científico publicado en 2013

Serum lipidome unravels a diagnostic potential in bile acid diarrhoea

artículo científico publicado en 2023

Single cell profiling reveals window for immunotherapy in liver cancers.

artículo científico publicado en 2018

Stage-associated overexpression of the ubiquitin-like protein, ISG15, in bladder cancer

artículo científico publicado en 2006

Stimulating translational research: several European life science institutions put their heads together.

artículo científico publicado en 2015

TREM-2 defends the liver against hepatocellular carcinoma through multifactorial protective mechanisms

scientific article published on 09 September 2020

Targeting the mTOR pathway in hepatocellular carcinoma: current state and future trends

artículo científico publicado en 2014

The protein kinase CK2 contributes to the malignant phenotype of cholangiocarcinoma cells

artículo científico publicado en 2019

Transcriptional, post-transcriptional and chromatin-associated regulation of pri-miRNAs, pre-miRNAs and moRNAs

artículo científico publicado en 2015

Transcriptomic and histopathological analysis of cholangiolocellular differentiation trait in intrahepatic cholangiocarcinoma.

artículo científico publicado en 2017

UBE1L causes lung cancer growth suppression by targeting cyclin D1.

artículo científico publicado en 2008

Whole blood microRNAs capture systemic reprogramming and have diagnostic potential in patients with biliary tract cancer

artículo científico publicado en 2022

mTOR inhibitors synergize on regression, reversal of gene expression, and autophagy in hepatocellular carcinoma.

artículo científico publicado en 2012

p53-dependent Nestin regulation links tumor suppression to cellular plasticity in liver cancer

artículo científico publicado en 2014

Lista de obras de Jesper B. Andersen

A Gene Expression Signature Associated with Overall Survival in Patients with Hepatocellular Carcinoma Suggests a New Treatment Strategy.

A Pan-Cancer Analysis Reveals High-Frequency Genetic Alterations in Mediators of Signaling by the TGF-β Superfamily

A morphogenetic EphB/EphrinB code controls hepatopancreatic duct formation

A perspective on molecular therapy in cholangiocarcinoma: present status and future directions.

Advances in cholangiocarcinoma research: report from the third Cholangiocarcinoma Foundation Annual Conference

Adverse genomic alterations and stemness features are induced by field cancerization in the microenvironment of hepatocellular carcinomas

An integrated genomic and epigenomic approach predicts therapeutic response to zebularine in human liver cancer

An integrative approach unveils FOSL1 as an oncogene vulnerability in KRAS-driven lung and pancreatic cancer.

Antitumor effects in hepatocarcinoma of isoform-selective inhibition of HDAC2.

Application of patient-derived liver cancer cells for phenotypic characterization and therapeutic target identification

Causes of hOCT1-Dependent Cholangiocarcinoma Resistance to Sorafenib and Sensitization by Tumor-Selective Gene Therapy

Cholangiocarcinoma 2020: the next horizon in mechanisms and management

Cholangiocarcinoma stem-like subset shapes tumor-initiating niche by educating associated macrophages

Cholangiocarcinoma: State-of-the-art knowledge and challenges

Coactivation of AKT and β-Catenin in Mice Rapidly Induces Formation of Lipogenic Liver Tumors ⬇️

Common Molecular Subtypes Among Asian Hepatocellular Carcinoma and Cholangiocarcinoma.

Curcumin effectively inhibits oncogenic NF-κB signaling and restrains stemness features in liver cancer

DNMT1 is a required genomic regulator for murine liver histogenesis and regeneration.

Desmoplastic Tumor Microenvironment and Immunotherapy in Cholangiocarcinoma.

Differential effects of FXR or TGR5 activation in cholangiocarcinoma progression

Dual-initiation promoters with intertwined canonical and TCT/TOP transcription start sites diversify transcript processing

Dysregulation of Iron Metabolism in Cholangiocarcinoma Stem-like Cells

Epigenetic events involved in organic cation transporter 1-dependent impaired response of hepatocellular carcinoma to sorafenib

Epigenetic reprogramming modulates malignant properties of human liver cancer.

Epigenome dysregulation in cholangiocarcinoma.

Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA).

Fibrolamellar hepatocellular carcinoma: a rare but distinct type of liver cancer

Functional and genetic deconstruction of the cellular origin in liver cancer.

Genetic Optimization of Liver Cancer Therapy: A Patient-Derived Primary Cancer Cell-Based Model

Genomic Perturbations Reveal Distinct Regulatory Networks in Intrahepatic Cholangiocarcinoma

Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors

Genomic decoding of intrahepatic cholangiocarcinoma reveals therapeutic opportunities.

Heterogeneity Among Liver Cancer—A Hurdle to Optimizing Therapy

High mobility group A1 enhances tumorigenicity of human cholangiocarcinoma and confers resistance to therapy.

Human hepatic cancer stem cells are characterized by common stemness traits and diverse oncogenic pathways.

Identification of a Pan-Gamma-Secretase Inhibitor Response Signature for Notch-Driven Cholangiocarcinoma

Impact of microenvironment and stem-like plasticity in cholangiocarcinoma: molecular networks and biological concepts.

Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles

Interaction between the 2'-5' oligoadenylate synthetase-like protein p59 OASL and the transcriptional repressor methyl CpG-binding protein 1

Liver cancer oncogenomics: opportunities and dilemmas for clinical applications

Long noncoding RNA HOTTIP/HOXA13 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients

Loss of c-Met disrupts gene expression program required for G2/M progression during liver regeneration in mice

Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties

MIR21 drives resistance to Heat Shock Protein 90 inhibition in cholangiocarcinoma

MYC activates stem-like cell potential in hepatocarcinoma by a p53-dependent mechanism.

Metabolic rearrangements in primary liver cancers: cause and consequences

MicroRNA-27a-3p targets FoxO signalling to induce tumour-like phenotypes in bile duct cells

Modeling pathogenesis of primary liver cancer in lineage-specific mouse cell types.

Molecular Pathogenesis and Current Therapy in Intrahepatic Cholangiocarcinoma

Molecular constituents of the extracellular matrix in rat liver mounting a hepatic progenitor cell response for tissue repair.

Molecular pathogenesis of intrahepatic cholangiocarcinoma

Molecular perturbations in cholangiocarcinoma: Is it time for precision medicine?

Molecular profiling of intrahepatic cholangiocarcinoma: the search for new therapeutic targets

Next-generation sequencing: application in liver cancer-past, present and future?

Notch signaling inhibits hepatocellular carcinoma following inactivation of the RB pathway.

Oncogenic driver genes and the inflammatory microenvironment dictate liver tumor phenotype

Phosphoprotein enriched in diabetes (PED/PEA15) promotes migration in hepatocellular carcinoma and confers resistance to sorafenib.

Post-transcriptional regulation of RNase-L expression is mediated by the 3'-untranslated region of its mRNA

Progenitor-derived hepatocellular carcinoma model in the rat.

RNAi screening of subtracted transcriptomes reveals tumor suppression by taurine-activated GABAA receptors involved in volume regulation.

Reply

Role of 2-5A-dependent RNase-L in senescence and longevity.

SOX17 regulates cholangiocyte differentiation and acts as a tumor suppressor in cholangiocarcinoma.

Sequential transcriptome analysis of human liver cancer indicates late stage acquisition of malignant traits.

Serum lipidome unravels a diagnostic potential in bile acid diarrhoea

Single cell profiling reveals window for immunotherapy in liver cancers.

Stage-associated overexpression of the ubiquitin-like protein, ISG15, in bladder cancer

Stimulating translational research: several European life science institutions put their heads together.

TREM-2 defends the liver against hepatocellular carcinoma through multifactorial protective mechanisms

Targeting the mTOR pathway in hepatocellular carcinoma: current state and future trends

The protein kinase CK2 contributes to the malignant phenotype of cholangiocarcinoma cells

Transcriptional, post-transcriptional and chromatin-associated regulation of pri-miRNAs, pre-miRNAs and moRNAs

Transcriptomic and histopathological analysis of cholangiolocellular differentiation trait in intrahepatic cholangiocarcinoma.

UBE1L causes lung cancer growth suppression by targeting cyclin D1.

Whole blood microRNAs capture systemic reprogramming and have diagnostic potential in patients with biliary tract cancer

mTOR inhibitors synergize on regression, reversal of gene expression, and autophagy in hepatocellular carcinoma.

p53-dependent Nestin regulation links tumor suppression to cellular plasticity in liver cancer